Dover Corporation · DOV · FY2025 Q3 · Calendar Q4 2025
Dover posts solid Q3, raises EPS guidance on broad demand
Dover's Q3 analysis supports a constructive operating trajectory: broad order momentum, margin expansion, secular end-market exposure, and acquisitions supported a guidance increase. The case remains dependent on converting orders efficiently and sustaining demand despite tariff, refrigeration, and macro risks.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about DOV FY2025 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The quarter added evidence of broad shipment growth, a record 26.1% consolidated EBITDA margin, strong early acquisition performance, and a higher full-year EPS range. Management also emphasized continued investment in data-center cooling, clean-energy and refrigeration platforms, alongside potential buybacks.
Guidance delta
Full-year adjusted EPS guidance was raised to $9.50-$9.60 from $9.35-$9.55 previously.
Key takeaways
- Revenue increased 5% year over year and adjusted EPS increased 15%.
- Consolidated EBITDA margin reached a record 26.1%, up 170 basis points year over year.
- Data-center cooling, clean-energy fueling, CO2 refrigeration, and biopharma components were identified as growth platforms.
- Site IQ and SIKORA were described as performing strongly, while further capital investment remains planned.
Management priorities
- Continue high-return productivity and capacity projects.
- Expand SIKORA operations to two additional sites over the next 24 months.
- Launch thermal-connector and heat-exchanger products for data-center cooling.
- Expand CO2 refrigeration and retail-fueling platforms.
- Consider share repurchases supported by free-cash-flow generation.
Follow DOV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 6, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 24, 2026 |
| BMO Capital | Outperform | Market Perform | Upgrade | Jul 24, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 4, 2026 |
| Seaport Global | Buy | Buy | Maintain | Apr 28, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 24, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Apr 24, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 24, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 13, 2026 |
| Wells Fargo | Overweight | Equal Weight | Upgrade | Mar 17, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 30, 2026 |
| UBS | Buy | Neutral | Upgrade | Jan 5, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 13, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Dec 12, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Oct 28, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 26, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 12, 2023 |
| B of A Securities | Buy | Buy | Maintain | Apr 11, 2023 |
| Bank of America | Buy | Buy | Maintain | Sep 26, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Sep 12, 2018 |
| Stifel | Hold | Hold | Maintain | Sep 12, 2018 |
| Vertical Research | Buy | Hold | Upgrade | Jan 3, 2017 |
| Susquehanna | Neutral | Neutral | Maintain | Oct 7, 2016 |
| Bernstein | Outperform | Market Perform | Upgrade | Jun 10, 2016 |
| Nomura | Buy | Buy | Maintain | Mar 7, 2016 |
| William Blair | Market Perform | Outperform | Downgrade | Dec 16, 2015 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Nov 3, 2015 |
| Global Hunter Securities | Buy | Buy | Maintain | Oct 18, 2013 |
| Ascendiant Capital | Neutral | Buy | Downgrade | Oct 18, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $191.3. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Stephen Tusa | $229 | $187.89 | +19.7% | Sep 24, 2026 |
| RBC Capital | Analyst unavailable | $227 | $203.68 | +18.7% | Jul 24, 2026 |
| Robert W. Baird | Michael Halloran | $270 | $197.8 | +41.1% | Jul 24, 2026 |
| BMO Capital | Daniel DiCicco | $240 | $197.8 | +25.5% | Jul 24, 2026 |
| Wolfe Research | Nigel Coe | $262 | $213.55 | +37.0% | Jul 9, 2026 |
| Morgan Stanley | Christopher Snyder | $230 | $215.74 | +20.2% | Jun 4, 2026 |
| Seaport Global | Analyst unavailable | $265 | $224.49 | +38.5% | Apr 28, 2026 |
| Deutsche Bank | Analyst unavailable | $229 | $227.3 | +19.7% | Apr 24, 2026 |
| RBC Capital | Analyst unavailable | $252 | $227.3 | +31.7% | Apr 24, 2026 |
| BMO Capital | Daniel DiCicco | $250 | $228.47 | +30.7% | Apr 24, 2026 |
| Oppenheimer | Bryan Blair | $250 | $228.15 | +30.7% | Apr 24, 2026 |
| Robert W. Baird | Michael Halloran | $279 | $228.15 | +45.8% | Apr 24, 2026 |
| Barclays | Julian Mitchell | $230 | $228.15 | +20.2% | Apr 24, 2026 |
| BMO Capital | Analyst unavailable | $237 | $209.21 | +23.9% | Mar 26, 2026 |
| Morgan Stanley | Christopher Snyder | $210 | $216.32 | +9.8% | Feb 4, 2026 |
| Seaport Global | Analyst unavailable | $245 | $210.52 | +28.1% | Feb 3, 2026 |
| Barclays | Analyst unavailable | $206 | $201.49 | +7.7% | Feb 2, 2026 |
| Goldman Sachs | Analyst unavailable | $224 | $201.49 | +17.1% | Jan 31, 2026 |
| RBC Capital | Analyst unavailable | $209 | $202.53 | +9.3% | Jan 30, 2026 |
| Robert W. Baird | Analyst unavailable | $255 | $204.72 | +33.3% | Jan 30, 2026 |
| Oppenheimer | Analyst unavailable | $232 | $207.49 | +21.3% | Jan 26, 2026 |
| RBC Capital | Deane Dray | $199 | $207.64 | +4.0% | Jan 15, 2026 |
| Wells Fargo | Joseph O'Dea | $205 | $203.5 | +7.2% | Jan 7, 2026 |
| UBS | Amit Mehrotra | $256 | $195.75 | +33.8% | Jan 4, 2026 |
| BNP Paribas | Analyst unavailable | $195 | $190.27 | +1.9% | Dec 4, 2025 |
| Morgan Stanley | Analyst unavailable | $195 | $178.94 | +1.9% | Oct 28, 2025 |
| RBC Capital | Deane Dray | $198 | $179.82 | +3.5% | Oct 24, 2025 |
| Robert W. Baird | Analyst unavailable | $235 | $179.82 | +22.8% | Oct 24, 2025 |
| UBS | Analyst unavailable | $200 | $179.82 | +4.5% | Oct 24, 2025 |
| RBC Capital | Deane Dray | $206 | $186.5 | +7.7% | Jul 25, 2025 |
| Mizuho Securities | Brett Linzey | $215 | $186.7 | +12.4% | May 16, 2025 |
| RBC Capital | Analyst unavailable | $176 | $169.01 | -8.0% | Apr 25, 2025 |
| Morgan Stanley | Christopher Snyder | $185 | $163.66 | -3.3% | Apr 14, 2025 |
| Barclays | Analyst unavailable | $205 | $184.22 | +7.2% | Mar 26, 2025 |
| Wells Fargo | Joseph O'Dea | $200 | $187.98 | +4.5% | Jan 7, 2025 |
| UBS | Amit Mehrotra | $217 | $176.23 | +13.4% | Nov 13, 2024 |
| Goldman Sachs | Joe Ritchie | $202 | $191.84 | +5.6% | Oct 30, 2024 |
| Wolfe Research | Nigel Coe | $227 | $191.03 | +18.7% | Oct 28, 2024 |
| Bank of America Securities | Andrew Obin | $210 | $192.79 | +9.8% | Oct 17, 2024 |
| Oppenheimer | Bryan Blair | $215 | $191.28 | +12.4% | Oct 16, 2024 |
| Citigroup | Andrew Kaplowitz | $218 | $189.12 | +14.0% | Sep 23, 2024 |
| RBC Capital | Deane Dray | $193 | $187.03 | +0.9% | Jul 26, 2024 |
| Robert W. Baird | Michael Halloran | $219 | $186.32 | +14.5% | Jul 25, 2024 |
| RBC Capital | Deane Dray | $179 | $173.2 | -6.4% | Apr 4, 2024 |
| Seaport Global | Walt Liptak | $190 | $159.99 | -0.7% | Feb 5, 2024 |
| Morgan Stanley | Analyst unavailable | $152 | $152.88 | -20.5% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $157 | $154.66 | -17.9% | Feb 1, 2023 |
| Credit Suisse | Analyst unavailable | $174 | $152.35 | -9.0% | Feb 1, 2023 |
| Morgan Stanley | Joshua Pokrzywinski | $139 | $119.36 | -27.3% | Oct 12, 2022 |
| Deutsche Bank | Nicole DeBlase | $132 | $128.25 | -31.0% | Jul 22, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $149 | $133.19 | -22.1% | Jun 7, 2022 |
| Morgan Stanley | Analyst unavailable | $161 | $140.87 | -15.8% | Apr 22, 2022 |
| Barclays | Analyst unavailable | $155 | $140.86 | -19.0% | Apr 22, 2022 |
| Wells Fargo | Analyst unavailable | $159 | $141 | -16.9% | Apr 22, 2022 |
| RBC Capital | Analyst unavailable | $162 | $144.16 | -15.3% | Apr 22, 2022 |
| Barclays | Julian Mitchell | $190 | $153.92 | -0.7% | Apr 5, 2022 |
| Deutsche Bank | Nicole Deblase | $176 | $178.77 | -8.0% | Jan 10, 2022 |
| Wells Fargo | Joseph O'Dea | $184 | $168.44 | -3.8% | Dec 20, 2021 |
| Bank of America Securities | Andrew Obin | $205 | $167.82 | +7.2% | Oct 20, 2021 |
Track every rating change on DOV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationDover Corporation operates as a global enterprise, supplying a wide array of industrial equipment, essential components, consumable products, replacement parts, software and digital platforms, and comprehensive support services. Its Engineered Products division delivers diverse machinery, parts, software, and solutions tailored for various industries, including automotive aftermarket service, waste management, industrial automation, aerospace and defense, heavy-duty winching and hoisting, and fluid dispensing. This segment also manufactures specific items such as manual and power clamps, rotary and linear mechanical indexers, conveyors, robotic pick-and-place units, glove ports, manipulators, and end-of-arm tooling like grippers, slides, and end effectors. The Clean Energy & Fueling segment focuses on providing components, equipment, software, and services crucial for the secure transportation of both traditional and sustainable fuels, along with other hazardous materials, throughout the supply chain.…
Historical context
All DOV earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the DOV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-06T07:20:44.708425+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-06T07:20:44.705637+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-06. For educational purposes only; not investment advice.